IL6 and non-small cell lung carcinoma: Collectively, these results indicate that elevated IL-6 levels within the NSCLC tumor microenvironment promote the ubiquitination and subsequent degradation of NKp30 in NK cells by activating the STAT3-UBE2S signaling axis, thereby impairing NK cell cytotoxic function.